Western General Hospital, EH42XU, Edinburgh, UK.
Sunderland Royal Hospital, Kayll Rd, Sunderland, SR4 7TP, UK.
Langenbecks Arch Surg. 2023 Oct 24;408(1):416. doi: 10.1007/s00423-023-03152-4.
Robotic-assisted surgery (RAS) offers potential advantages over traditional surgical approaches. This study aimed to assess outcomes from a district general hospital (DGH) robotic colorectal programme against published data.
The robotic programme was established following simulator, dry/wet lab training, and proctoring. We performed a case series analysing technical, patient, and oncological outcomes extracted from a prospective database of colorectal RAS cases (2015-2022). A registered systematic review (PROSPERO CRD42022300773; PubMed, Web of Science, EMBASE) of single-centre colorectal series from established robotic centres (n>200 cases) was completed and compared to local data using descriptive summary statistics. Risk of bias assessment was performed using an adapted version of the Cochrane ROBINS-I tool.
Two hundred thirty-two RAS cases were performed including 122 anterior resections, 56 APERs, 19 rectopexies, and 15 Hartmann's procedures. The median duration was 325 (IQR 265-400) min. Blood loss was < 100 ml in 97% of cases with 2 (0.9%) cases converted to open. Complications (Clavien-Dindo 3-5) occurred in 19 (8%) patients, with 3 (1.3%) deaths in < 30 days. Length of stay was 7 (IQR 5-11) days. In 169 rectal cancer cases, there were 9 (5.3%) cases with a positive circumferential or distal margin and lymph node yield of 17 (IQR 13-24). A systematic review of 1648 abstracts identified 13 studies from established robotic centres, totaling 4930 cases, with technical, patient, and oncological outcomes comparable to our own case series.
Outcomes from our robotic colorectal programme at a UK DGH are comparable with the largest published case series from world-renowned centres. Training and proctoring together with rolling audit must accompany the expansion of robotic surgery to safeguard outcomes.
机器人辅助手术(RAS)提供了优于传统手术方法的潜在优势。本研究旨在评估一家地区综合医院(DGH)的机器人结直肠计划的结果,并与已发表的数据进行比较。
在完成模拟器、干/湿实验室培训和监督后,我们建立了机器人程序。我们进行了一项病例系列分析,从机器人结直肠手术的前瞻性数据库中提取了技术、患者和肿瘤学结果(2015-2022 年)。完成了对来自已建立的机器人中心(>200 例病例)的单中心结直肠系列的已注册系统评价(PROSPERO CRD42022300773;PubMed、Web of Science、EMBASE),并使用描述性汇总统计数据与本地数据进行比较。使用 Cochrane ROBINS-I 工具的改编版本进行了风险偏倚评估。
共完成 232 例 RAS 手术,包括 122 例前切除术、56 例 APER、19 例直肠固定术和 15 例 Hartmann 手术。中位时间为 325(IQR 265-400)分钟。97%的病例出血量<100ml,2 例(0.9%)转为开放性。19 例(8%)患者发生并发症(Clavien-Dindo 3-5),<30 天内 3 例(1.3%)死亡。住院时间为 7(IQR 5-11)天。在 169 例直肠癌病例中,有 9 例(5.3%)存在环周或远端切缘阳性,淋巴结检出量为 17(IQR 13-24)。对 1648 份摘要进行的系统评价确定了来自知名机器人中心的 13 项研究,共 4930 例病例,其技术、患者和肿瘤学结果与我们自己的病例系列相似。
英国 DGH 的机器人结直肠计划的结果与来自世界知名中心的最大已发表病例系列相似。培训和监督以及滚动审核必须伴随机器人手术的扩展,以保证结果。